| SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein EA Albornoz, AA Amarilla, N Modhiran, S Parker, XX Li, DK Wijesundara, ... Molecular psychiatry 28 (7), 2878-2893, 2023 | 75 | 2023 |
| Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2 D Watterson, DK Wijesundara, N Modhiran, FL Mordant, Z Li, ... Clinical & translational immunology 10 (4), e1269, 2021 | 54 | 2021 |
| Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine CLD McMillan, JJY Choo, A Idris, A Supramaniam, N Modhiran, ... Science advances 7 (44), eabj8065, 2021 | 39 | 2021 |
| A novel purification procedure for active recombinant human DPP4 and the inability of DPP4 to bind SARS-CoV-2 CR Xi, A Di Fazio, NA Nadvi, K Patel, MSW Xiang, HE Zhang, ... Molecules 25 (22), 5392, 2020 | 32 | 2020 |
| Bovine herpesvirus-4-vectored delivery of Nipah virus glycoproteins enhances T cell immunogenicity in pigs M Pedrera, F Macchi, RK McLean, V Franceschi, N Thakur, L Russo, ... Vaccines 8 (1), 115, 2020 | 30 | 2020 |
| Micro-fusion inhibition tests: quantifying antibody neutralization of virus-mediated cell–cell fusion N Thakur, C Conceicao, A Isaacs, S Human, N Modhiran, RK McLean, ... Journal of General Virology 102 (1), 001506, 2021 | 24 | 2021 |
| Adjuvant selection for influenza and RSV prefusion subunit vaccines A Isaacs, Z Li, STM Cheung, DK Wijesundara, CLD McMillan, N Modhiran, ... Vaccines 9 (2), 71, 2021 | 15 | 2021 |
| Molecular clamp stabilised Spike protein for protection against SARS-CoV-2 D Watterson, D Wijesundara, N Modhiran, F Mordant, Z Li, M Avumegah, ... | 15 | 2020 |
| Combinatorial FG immunogens as Nipah and respiratory syncytial virus vaccine candidates A Isaacs, STM Cheung, N Thakur, N Jaberolansar, A Young, N Modhiran, ... Viruses 13 (10), 1942, 2021 | 14 | 2021 |
| Rapid response subunit vaccine design in the absence of structural information DK Wijesundara, MS Avumegah, J Lackenby, N Modhiran, A Isaacs, ... Frontiers in immunology 11, 592370, 2020 | 14 | 2020 |
| Nucleocapsid specific diagnostics for the detection of divergent SARS-CoV-2 variants A Isaacs, AA Amarilla, J Aguado, N Modhiran, EA Albornoz, AA Baradar, ... Frontiers in Immunology 13, 926262, 2022 | 12 | 2022 |
| A platform technology for generating subunit vaccines against diverse viral pathogens A Young, A Isaacs, CAP Scott, N Modhiran, CLD McMillan, STM Cheung, ... Frontiers in Immunology 13, 963023, 2022 | 11 | 2022 |
| Monoclonal antibodies specific for SARS-CoV-2 spike protein suitable for multiple applications for current variants of concern MS Morgan, K Yan, TT Le, RA Johnston, AA Amarilla, DA Muller, ... Viruses 15 (1), 139, 2022 | 9 | 2022 |
| Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathology J Aguado, AA Amarilla, A Taherian Fard, EA Albornoz, A Tyshkovskiy, ... Nature Aging 3 (12), 1561-1575, 2023 | 7 | 2023 |
| Structure and antigenicity of divergent Henipavirus fusion glycoproteins A Isaacs, YS Low, KL Macauslane, J Seitanidou, CL Pegg, STM Cheung, ... Nature communications 14 (1), 3577, 2023 | 7 | 2023 |
| Characterization and comparison of novel adjuvants for a prefusion clamped MERS vaccine JS O’Donnell, A Isaacs, V Jakob, C Lebas, JB Barnes, PC Reading, ... Frontiers in immunology 13, 976968, 2022 | 6 | 2022 |
| Dermal delivery of a SARS-CoV-2 subunit vaccine induces immunogenicity against variants of concern CLD McMillan, A Azuar, JJY Choo, N Modhiran, AA Amarilla, A Isaacs, ... Vaccines 10 (4), 578, 2022 | 6 | 2022 |
| SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike-ACE2 receptor interaction E Albornoz, AA Amarilla, N Modhiran, S Parker, XX Li, DK Wijesundara, ... bioRxiv, 2022.01. 11.475947, 2022 | 5 | 2022 |
| A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variants N Modhiran, SM Lauer, AA Amarilla, P Hewins, SIL van den Broek, ... Iscience 26 (7), 107085, 2023 | 4 | 2023 |
| Concerns regarding vaccination as a management strategy against koala retrovirus BA Joyce, D Watterson, A Isaacs, KJ Chappell bioRxiv, 2021.05. 10.443397, 2021 | 1 | 2021 |
